- Home
- AZTR vs INM Comparison
AZTR vs INM Comparison
Compare AZTR & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZTR
- INM
- Stock Information
- Founded
- AZTR 2014
- INM 1981
- Country
- AZTR United States
- INM Canada
- Employees
- AZTR N/A
- INM N/A
- Industry
- AZTR Biotechnology: Pharmaceutical Preparations
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- AZTR Health Care
- INM Health Care
- Exchange
- AZTR Nasdaq
- INM Nasdaq
- Market Cap
- AZTR 3.2M
- INM 3.4M
- IPO Year
- AZTR 2023
- INM N/A
- Fundamental
- Price
- AZTR $0.25
- INM $4.95
- Analyst Decision
- AZTR
- INM
- Analyst Count
- AZTR 0
- INM 0
- Target Price
- AZTR N/A
- INM N/A
- AVG Volume (30 Days)
- AZTR 3.0M
- INM 26.6K
- Earning Date
- AZTR 03-14-2025
- INM 02-11-2025
- Dividend Yield
- AZTR N/A
- INM N/A
- EPS Growth
- AZTR N/A
- INM N/A
- EPS
- AZTR N/A
- INM N/A
- Revenue
- AZTR $97,500.00
- INM $4,960,506.00
- Revenue This Year
- AZTR N/A
- INM N/A
- Revenue Next Year
- AZTR N/A
- INM N/A
- P/E Ratio
- AZTR N/A
- INM N/A
- Revenue Growth
- AZTR N/A
- INM 5.17
- 52 Week Low
- AZTR $0.24
- INM $2.42
- 52 Week High
- AZTR $68.40
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- AZTR 36.62
- INM 55.90
- Support Level
- AZTR $0.24
- INM $4.07
- Resistance Level
- AZTR $0.65
- INM $5.41
- Average True Range (ATR)
- AZTR 0.06
- INM 0.39
- MACD
- AZTR -0.02
- INM 0.01
- Stochastic Oscillator
- AZTR 1.71
- INM 67.83
About AZTR Azitra Inc
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.